REG - GSK PLC - Director/PDMR Shareholding

GSKAnnouncement

09/05/2023 15:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230509:nRSI8205Ya&default-theme=true

RNS Number : 8205Y  GSK PLC  09 May 2023

GSK plc (the 'Company')

Transaction notification

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Sir Jonathan Symonds
 b)  Position/status                          Non-Executive Chair
 c)  Initial notification/                    Initial notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GSK plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  Ordinary shares of 31 ¼ pence each ('Ordinary Shares')

                                              ISIN: GB00BN7SWP63
 b)  Nature of the transaction                Release of 35,439 notional Ordinary Shares from the GSK Non-Executive Director
                                              Share Allocation Arrangements prior to termination of those arrangements, the
                                              withholding of 16,656 notional Ordinary Shares for tax and the final release
                                              of 18,782 Ordinary Shares representing the balance. These shares will be held
                                              by Sir Jonathan Symonds until he retires from the Board
 c)  Price(s) and volume(s)                                         Price(s)              Volume(s)
                                                                    £14.556               18,782

 d)  Aggregated information                   N/A (single transaction)

     Aggregated volume Price
 e)  Date of the transaction                  2023-05-04
 f)  Place of the transaction                 London Stock Exchange (XLON)

 

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Mr Urs Rohner
 b)  Position/status                          Independent Non-Executive Director
 c)  Initial notification/                    Initial notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GSK plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  Ordinary shares of 31 ¼ pence each ('Ordinary Shares')

                                              ISIN: GB00BN7SWP63
 b)  Nature of the transaction                Release of 19,083 notional Ordinary Shares from the GSK Non-Executive Director
                                              Share Allocation Arrangements prior to termination of those arrangements, the
                                              withholding of 4,446 notional Ordinary Shares for tax and the final release of
                                              14,637 Ordinary Shares representing the balance. These shares will be held by
                                              Mr Rohner until he retires from the Board
 c)  Price(s) and volume(s)                                         Price(s)              Volume(s)
                                                                    £14.556               14,637

 d)  Aggregated information                   N/A (single transaction)

     Aggregated volume Price
 e)  Date of the transaction                  2023-05-04
 f)  Place of the transaction                 London Stock Exchange (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHSSFFFUEDSEDI